Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Fabbro

Showing results (141-150 of 167) with videos related to

Pageof 17
Sort By:
Oncogene|July 9, 2013
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biologyC Vascotto, L Lirussi, M Poletto, et al.
Behavioural Pharmacology|February 28, 2013
Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-α and thalidomide therapiesLeandro C Souza, Carlos B Filho, Lucian D Fabbro, et al.
Oncogene|June 26, 2015
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biologyC Vascotto, L Lirussi, M Poletto, et al.
Anti-Cancer Drug Design|July 11, 2000
PKC412--a protein kinase inhibitor with a broad therapeutic potentialD Fabbro, S Ruetz, S Bodis, et al.
Cancer Research|June 13, 2000
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapyR A Olie, A P Simões-Wüst, B Baumann, et al.
Anti-Cancer Drug Design|July 1, 1997
Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeuticsK McGraw, R McKay, L Miraglia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitroI Recchia, N Rucci, C Festuccia, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinomaK Matušan-Ilijaš, G Damante, D Fabbro, et al.
European Journal of Biochemistry|November 15, 1995
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2F Meggio, A Donella Deana, M Ruzzene, et al.
Nucleic Acids Research|August 11, 1994
Sequence-specific DNA recognition by the thyroid transcription factor-1 homeodomainG Damante, D Fabbro, L Pellizzari, et al.
Pageof 17

Showing results (141-150 of 167) with videos related to

Sort By:
Pageof 17
Oncogene|July 9, 2013
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biologyC Vascotto, L Lirussi, M Poletto, et al.
Behavioural Pharmacology|February 28, 2013
Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice: the protective effect of fluoxetine, antitumour necrosis factor-α and thalidomide therapiesLeandro C Souza, Carlos B Filho, Lucian D Fabbro, et al.
Oncogene|June 26, 2015
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biologyC Vascotto, L Lirussi, M Poletto, et al.
Anti-Cancer Drug Design|July 11, 2000
PKC412--a protein kinase inhibitor with a broad therapeutic potentialD Fabbro, S Ruetz, S Bodis, et al.
Cancer Research|June 13, 2000
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapyR A Olie, A P Simões-Wüst, B Baumann, et al.
Anti-Cancer Drug Design|July 1, 1997
Antisense oligonucleotide inhibitors of isozymes of protein kinase C: in vitro and in vivo activity, and clinical development as anti-cancer therapeuticsK McGraw, R McKay, L Miraglia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2003
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitroI Recchia, N Rucci, C Festuccia, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinomaK Matušan-Ilijaš, G Damante, D Fabbro, et al.
European Journal of Biochemistry|November 15, 1995
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2F Meggio, A Donella Deana, M Ruzzene, et al.
Nucleic Acids Research|August 11, 1994
Sequence-specific DNA recognition by the thyroid transcription factor-1 homeodomainG Damante, D Fabbro, L Pellizzari, et al.
Pageof 17